IL122665A - Method and apparatus for inactivating contaminants in blood products - Google Patents

Method and apparatus for inactivating contaminants in blood products

Info

Publication number
IL122665A
IL122665A IL12266596A IL12266596A IL122665A IL 122665 A IL122665 A IL 122665A IL 12266596 A IL12266596 A IL 12266596A IL 12266596 A IL12266596 A IL 12266596A IL 122665 A IL122665 A IL 122665A
Authority
IL
Israel
Prior art keywords
pct
fibrinogen concentrate
viral
fibrinogen
date
Prior art date
Application number
IL12266596A
Other languages
English (en)
Other versions
IL122665A0 (en
Original Assignee
Croix Rouge De Belgique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8218658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122665(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croix Rouge De Belgique filed Critical Croix Rouge De Belgique
Priority claimed from PCT/BE1996/000076 external-priority patent/WO1997003706A1/fr
Publication of IL122665A0 publication Critical patent/IL122665A0/xx
Publication of IL122665A publication Critical patent/IL122665A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
IL12266596A 1994-07-14 1996-07-15 Method and apparatus for inactivating contaminants in blood products IL122665A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94870121 1994-07-14
PCT/BE1995/000069 WO1996002571A1 (fr) 1994-07-14 1995-07-14 Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation
PCT/BE1996/000076 WO1997003706A1 (fr) 1995-07-14 1996-07-15 Procede et installation d'inactivation de contaminants presents dans des produits sanguins

Publications (2)

Publication Number Publication Date
IL122665A0 IL122665A0 (en) 1998-08-16
IL122665A true IL122665A (en) 2001-08-26

Family

ID=8218658

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12266596A IL122665A (en) 1994-07-14 1996-07-15 Method and apparatus for inactivating contaminants in blood products

Country Status (9)

Country Link
US (1) US5834420A (xx)
EP (1) EP0771324B2 (xx)
JP (1) JP4211894B2 (xx)
AT (1) ATE184884T1 (xx)
CA (1) CA2195127C (xx)
DE (1) DE69512416T3 (xx)
ES (1) ES2139227T5 (xx)
IL (1) IL122665A (xx)
WO (1) WO1996002571A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0771324B2 (fr) * 1994-07-14 2011-02-09 CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation
ATE367830T1 (de) * 1995-07-14 2007-08-15 Caf Dcf Cvba Scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
ES2262340T3 (es) * 1998-09-24 2006-11-16 Pharming Intellectual Property Bv Purificacion del fibrinogeno de la leche mediante el uso de cromatografia de intercambio cationico.
ES2267289T3 (es) * 1998-09-24 2007-03-01 Pharming Intellectual Property Bv Purificacion de fibrinogeno a partir de fluidos mediante precipitacion y cromatografia de interaccion hidrofoba.
FR2785206B1 (fr) * 1998-10-14 2001-01-19 Fond Jean Dausset Ceph Dispositif de centrifugation pour automate de laboratoire
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
CA2394797A1 (en) 1999-12-20 2001-06-28 Tsuyoshi Takahashi Process for producing virus-free plasma protein composition by porous membrane treatment, virus-free plasma protein composition and method of removing viruses
CA2395431C (en) * 1999-12-23 2010-08-17 Csl Limited Separation of fibrinogen from plasma proteases
US20030086817A1 (en) * 2001-11-06 2003-05-08 Horton Isaac B. Blood purification system
WO2003070285A1 (en) * 2002-02-19 2003-08-28 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
AU2004216476B2 (en) 2003-02-27 2009-01-08 Takeda Pharmaceutical Company Limited Method for the validatable inactivation of pathogens in a biological fluid by irradiation
US20050124038A1 (en) * 2003-07-14 2005-06-09 Pharmacia Corporation Transfection of cartilage and matrices thereof in vitro
EP2338441B1 (en) 2003-12-11 2013-01-23 Isto Technologies Inc. Particulate cartilage system
ATE553186T1 (de) * 2004-02-20 2012-04-15 Isto Technologies Inc Bandscheibenreparatur und verfahren dafür
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
CN101005859B (zh) * 2004-06-29 2012-08-15 利莱恩斯生命科学有限公司 灭病毒生物液体的制备方法
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101977635A (zh) * 2008-03-28 2011-02-16 医疗器械研究基金会 通过溶剂/去污剂处理对生物流体进行病毒灭活的方法
US9371355B2 (en) 2010-09-20 2016-06-21 Octapharma Ag Process for production of fibrinogen
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
RU2663792C2 (ru) * 2012-03-13 2018-08-09 Октафарма Аг Способ очистки фибриногена, продукт фибриногена и средство для очистки или производства продукта фибриногена
CH706420A1 (fr) * 2012-04-19 2013-10-31 Valerie Soulie Procédé d'inactivation virale d'un fluide biologique, dispositif et récipient pour la mise en œuvre d'un tel procédé.
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
CA3161383A1 (en) * 2019-12-10 2021-06-17 Vera OTT Method for manufacturing a fibrinogen preparation
CN111518197B (zh) * 2020-03-30 2024-01-05 哈尔滨派斯菲科生物制药有限公司 一种纤维蛋白原的生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4481189A (en) † 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) † 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
ES2057191T5 (es) † 1989-01-13 2003-05-01 Mitsubishi Pharma Corp Metodo de produccion para una composicion que contiene proteinas.
DE69229272T2 (de) * 1991-09-05 2000-02-03 Baxter International Inc., Deerfield Topischer fibrinogenkomplex
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
EP0771324B2 (fr) * 1994-07-14 2011-02-09 CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation

Also Published As

Publication number Publication date
CA2195127C (en) 2007-06-19
EP0771324A1 (fr) 1997-05-07
IL122665A0 (en) 1998-08-16
JP4211894B2 (ja) 2009-01-21
DE69512416D1 (de) 1999-10-28
US5834420A (en) 1998-11-10
WO1996002571A1 (fr) 1996-02-01
CA2195127A1 (en) 1996-02-01
EP0771324B2 (fr) 2011-02-09
DE69512416T2 (de) 2000-02-17
DE69512416T3 (de) 2011-12-15
JPH10506607A (ja) 1998-06-30
ATE184884T1 (de) 1999-10-15
EP0771324B1 (fr) 1999-09-22
ES2139227T3 (es) 2000-02-01
ES2139227T5 (es) 2011-05-04

Similar Documents

Publication Publication Date Title
IL122665A0 (en) Method and apparatus for inactivating contaminants in blood products
AU643101B2 (en) Process for removing hydrogen cyanide and ammonia from aqueous solutions
NO972268D0 (no) Fremgangsmåte og anlegg for behandling av avlöpsvann
GEP20001940B (en) Valaciclovir Hydrochloride in Essentially Anhydrous Crystalline Form, Processes for its Producing, Use and Method of Treatment
IN181859B (xx)
ATE91896T1 (de) Verfahren zur herstellung eines konzentrats des faktor viii-von willebrand-faktor-komplexes der blutgerinnung aus vollplasma.
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
AU6487286A (en) Antihemophilic factor by cold precipitation
GR3018983T3 (en) Process for the preparation of purified albumin solutions
FI915813A0 (fi) Menetelmä luonnollisesti tuotetun kymosiinin talteenottamiseksi
EP0399321A3 (en) Gel filtration of heat treated factor viii
ES2068000T3 (es) Separacion de metales de peroxiacidos o peroxisales acuosos.
FR2632302B1 (fr) Procede de recuperation d'acide citrique a partir d'une liqueur en contenant
DE59509246D1 (de) Verfahren zum chemischen modifizieren von alkylgruppenhaltigen thermoplasten
HUT61053A (en) Process for obtaining recombinant proteins
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
DE69413952D1 (de) Extraktion von zellgebundenem protein von bordetella
AU2731088A (en) Improvements in or relating to antihemophilic factor (AHF)
AU3823195A (en) Process for recovering citric acid
NZ516235A (en) Method for purification of proteins
KR890002412A (ko) 높은 pH에서의 중성 아미노산 회수
DE59504268D1 (de) Verfahren zur rückgewinnung von guanidinsalzen
FR2674536B1 (fr) Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired